| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |